Cargando…
Correction to: Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment options
Autores principales: | McAnena, Peter F., McGuire, Andrew, Ramli, A., Curran, C., Malone, C., McLaughlin, R., Barry, K., Brown, James A. L., Kerin, M. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851151/ https://www.ncbi.nlm.nih.gov/pubmed/29534688 http://dx.doi.org/10.1186/s12885-018-4174-3 |
Ejemplares similares
-
Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment options
por: McAnena, Peter F., et al.
Publicado: (2018) -
Differential impact of hormone receptor status on survival and recurrence for HER2 receptor-positive breast cancers treated with Trastuzumab
por: McGuire, Andrew, et al.
Publicado: (2017) -
Circulating Nucleosomes and Nucleosome Modifications as Biomarkers in Cancer
por: McAnena, Peter, et al.
Publicado: (2017) -
Effects of Age on the Detection and Management of Breast Cancer
por: McGuire, Andrew, et al.
Publicado: (2015) -
Clinicopathological response to neoadjuvant therapies and pathological complete response as a biomarker of survival in human epidermal growth factor receptor-2 enriched breast cancer – A retrospective cohort study
por: Davey, Matthew G., et al.
Publicado: (2021)